Welcome to our dedicated page for Levi Strauss & Co. SEC filings (Ticker: LEVI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Levi Strauss & Co. (NYSE: LEVI) SEC filings page brings together the company’s regulatory disclosures, which provide detailed insight into its operations as one of the world’s largest brand-name apparel companies and a global leader in jeanswear. Through documents such as Forms 8-K, 10-K and 10-Q, Levi Strauss & Co. reports on financial performance, capital structure, governance decisions and other material events affecting the business.
Recent Form 8-K filings illustrate the range of topics covered. The company has furnished earnings releases for quarterly results, outlining net revenue trends, regional performance, direct-to-consumer and e-commerce growth, margin metrics and updated guidance. Other 8-Ks describe leadership and governance changes, including the appointment or retirement of directors, new executive roles and related compensation arrangements under the 2019 Equity Incentive Plan.
Levi Strauss & Co. also uses 8-K filings to disclose financing and capital markets activities. For example, a July 2025 8-K details the issuance of €475 million 4.000% Senior Notes due 2030, including interest terms, redemption options, covenants and the use of proceeds to redeem existing notes. Additional filings address matters such as the frequency of shareholder advisory votes on executive compensation, reflecting board decisions following shareholder meetings.
On Stock Titan, these filings can be viewed alongside AI-powered summaries that highlight key points, explain technical language and point to items of potential interest, such as changes in leverage, governance structures or compensation policies. Users can quickly locate Levi Strauss & Co.’s annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and other exhibits, and can track how the company communicates financial results, strategic initiatives and governance developments to regulators and investors over time.
Levi Strauss & Co filing: Amendment No. 5 to a Schedule 13G/A shows The Vanguard Group reports zero beneficial ownership of Levi Strauss & Co. common stock following an internal realignment. The filing states that, in accordance with SEC Release No. 34-39538 (January 12, 1998), certain Vanguard subsidiaries now report separately, and Vanguard no longer is deemed to beneficially own those securities. The form is signed by Ashley Grim on 03/27/2026.
Levi Strauss & Co. is asking shareholders to vote at its April 22, 2026 virtual annual meeting and provides an overview of 2025 performance and governance. The company generated $6.3 billion in net revenue, 7% organic growth, with a record 61.7% gross margin and 11.4% adjusted EBIT margin. Adjusted diluted EPS grew 8%, and Levi’s returned $363 million to shareholders, up 26% from 2024.
The proxy seeks approval of three company proposals: electing Class I directors, an advisory vote on executive compensation, and ratifying the auditor, plus a shareholder proposal for a sustainability ROI bylaw change that the board opposes. Board chair Robert Eckert plans to step down as chair after the meeting and retire in 2026, with director Troy Alstead slated to become independent chair. The board highlights four new independent directors added over three years and emphasizes pay-for-performance, majority performance-based executive pay, and strong governance practices.
LEVI director Christopher J. McCormick reported awards linked to dividend equivalent rights (DERs) on the company’s common stock. On February 25, 2026, he acquired 37 shares of Class B Common Stock and 195 shares of Class A Common Stock at $0.00 per share through grant/award transactions, not open‑market purchases.
The DERs each represent a contingent right to receive one share of the relevant class of common stock upon settlement and generally vest in line with the underlying awards. Some related awards and DERs are already fully vested but subject to deferred delivery. Each share of Class B Common Stock is convertible into one share of Class A Common Stock and has no expiration date.
LEVI STRAUSS & CO director Jill Beraud received equity awards in both share classes. She acquired 89 shares of Class B Common Stock and 75 shares of Class A Common Stock on a grant or award basis at a price of $0 per share.
After these awards, she directly owns 14,285 shares of Class B Common Stock and 172,776 shares of Class A Common Stock. Footnotes explain these awards are dividend equivalent rights, which give a contingent right to receive one share upon settlement, with specified vesting, conversion, and deferral features.
Levi Strauss & Co. director Joshua E. Prime reported an acquisition of 125 dividend equivalent rights (DERs) tied to Class A Common Stock as a grant or award at a price of $0.00 per right. These DERs each represent a contingent right to receive one share of Class A stock upon settlement.
The DERs vest and are delivered on the same schedule as the underlying equity awards. Unvested awards and related DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. After this grant, Prime directly holds 64,837 Class A-related shares and rights in total, including awards subject to potential deferred delivery features.
Levi Strauss & Co. director Patrick Artemis acquired 89 dividend equivalent rights (DERs) tied to Class A Common Stock at no cost. Each DER represents a contingent right to receive one share upon settlement, vesting in line with the underlying equity awards. After this grant, Artemis directly holds 14,265 Class A shares.
Levi Strauss & Co. director Jenny J. Ming reported stock-based awards rather than open-market trades. On February 25, 2026, she acquired 101 shares of Class B Common Stock and 75 shares of Class A Common Stock at a stated price of $0.00 per share.
The Form 4 notes these are dividend equivalent rights (DERs), each representing a contingent right to receive one share upon settlement. The Class A–linked DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date, while the Class B–linked DERs are fully vested but subject to deferred delivery. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the holder’s option with no expiration date.
LEVI STRAUSS & CO director David S. Marberger received an equity award linked to company stock. He acquired 93 dividend equivalent rights (DERs) tied to Class A Common Stock at no cash cost, increasing his directly held stock-based units to 22,844.
The DERs represent the right to receive one Class A share for each unit upon settlement. They vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the related award grant, with some fully vested awards subject to deferred delivery.
LEVI STRAUSS & CO director Robert Eckert reported stock-based awards rather than open-market trades. He acquired 283 shares of Class B Common Stock and 316 shares of Class A Common Stock on a grant or award basis at a stated price of $0.00 per share.
The awards are structured as dividend equivalent rights (DERs), which each represent a contingent right to receive one share upon settlement. Related DERs generally vest in line with the underlying awards, with some DERs already fully vested and all subject to deferred delivery terms.